{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T17:55:56Z","timestamp":1791741356191,"version":"4.3.4"},"reference-count":91,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T00:00:00Z","timestamp":1476835200000},"content-version":"am","delay-in-days":353,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006928","name":"Ohio State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000185","name":"Defense Advanced Research Projects Agency","doi-asserted-by":"publisher","award":["W911NF-10-1-0264"],"award-info":[{"award-number":["W911NF-10-1-0264"]}],"id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.ijpharm.2015.09.059","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T23:17:37Z","timestamp":1443568657000},"page":"849-861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Evaluation of a biodegradable microparticulate polymer as a carrier for Burkholderia pseudomallei subunit vaccines in a mouse model of melioidosis"],"prefix":"10.1016","volume":"495","author":[{"given":"K.L.","family":"Schully","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.G.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Prouty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.D.","family":"Gallovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.J.","family":"Peine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.M.","family":"Bachelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.T.","family":"Pesce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Elberson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.M.","family":"Ainslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Keane-Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2015.09.059_bib0005","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.plipres.2004.12.001","article-title":"Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release","volume":"44","author":"Andresen","year":"2005","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0010","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1128\/IAI.70.9.5290-5294.2002","article-title":"A mutant of Burkholderia pseudomallei, auxotrophic in the branched chain amino acid biosynthetic pathway, is attenuated and protective in a murine model of melioidosis","volume":"70","author":"Atkins","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0015","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0264-410X(02)00521-2","article-title":"Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro","volume":"21","author":"Audran","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0020","doi-asserted-by":"crossref","first-page":"10494","DOI":"10.1021\/ja803947s","article-title":"Acetal-derivatized dextran: an acid-responsive biodegradable material for therapeutic applications","volume":"130","author":"Bachelder","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0025","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1021\/mp900311x","article-title":"In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants","volume":"7","author":"Bachelder","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0030","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ejps.2011.10.003","article-title":"Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: adjuvant- and site-dependent immunogenicity in mice","volume":"45","author":"Bal","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0035","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2004.06.006","article-title":"Adaptive immunity in melioidosis: a possible role for T cells in determining outcome of infection with Burkholderia pseudomallei","volume":"113","author":"Barnes","year":"2004","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.ijpharm.2015.09.059_bib0040","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1021\/mp900038e","article-title":"In vivo studies on the effect of co-encapsulation of CpG DNA and antigen in acid-degradable microparticle vaccines","volume":"6","author":"Beaudette","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0045","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-1759(03)00265-5","article-title":"Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation","volume":"281","author":"Betts","year":"2003","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0050","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0091-679X(04)75020-7","article-title":"Detection of T-cell degranulation: CD107a and b","volume":"75","author":"Betts","year":"2004","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0055","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1586\/14760584.7.9.1357","article-title":"Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei","volume":"7","author":"Bondi","year":"2008","journal-title":"Expert Rev. Vaccines"},{"issue":"Suppl. 1","key":"10.1016\/j.ijpharm.2015.09.059_bib0060","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/S0035-9203(08)70022-1","article-title":"Induction of protective immunity against Burkholderia pseudomallei using attenuated mutants with defects in the intracellular life cycle","volume":"102","author":"Breitbach","year":"2008","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0065","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1073\/pnas.0901592106","article-title":"Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy","volume":"106","author":"Broaders","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0070","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s11095-008-9562-y","article-title":"Role of particle size in phagocytosis of polymeric microspheres","volume":"25","author":"Champion","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0075","doi-asserted-by":"crossref","first-page":"949","DOI":"10.4049\/jimmunol.136.3.949","article-title":"A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-gamma","volume":"136","author":"Coffman","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0080","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ajpath.2011.03.031","article-title":"Low-dose exposure of C57BL\/6 mice to Burkholderia pseudomallei mimics chronic human melioidosis","volume":"179","author":"Conejero","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0085","first-page":"143","article-title":"Melioidosis","volume":"1","author":"Dance","year":"1990","journal-title":"Rev. Med. Microbiol."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0001-706X(99)00059-5","article-title":"Melioidosis as an emerging global problem","volume":"74","author":"Dance","year":"2000","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0095","first-page":"1099","article-title":"Melioidosis: pathogenesis and immunity in mice and hamsters. II. Studies with avirulent strains of Malleomyces pseudomallei","volume":"34","author":"Dannenberg","year":"1958","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0100","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s11095-008-9594-3","article-title":"Acidic microclimate pH distribution in PLGA microspheres monitored by confocal laser scanning microscopy","volume":"25","author":"Ding","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0105","doi-asserted-by":"crossref","first-page":"e10051","DOI":"10.1371\/journal.pone.0010051","article-title":"Macrophages recognize size and shape of their targets","volume":"5","author":"Doshi","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0110","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1574-695X.2007.00345.x","article-title":"Evaluating Burkholderia pseudomallei Bip proteins as vaccines and Bip antibodies as detection agents","volume":"52","author":"Druar","year":"2008","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"3","key":"10.1016\/j.ijpharm.2015.09.059_bib0115","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1021\/mp3005098","article-title":"Electrospray encapsulation of toll-like receptor agonist resiquimod in polymer microparticles for the treatment of visceral leishmaniasis","volume":"10","author":"Duong","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0120","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1021\/mp3005098","article-title":"Electrospray encapsulation of toll-like receptor agonist resiquimod in polymer microparticles for the treatment of visceral leishmaniasis","volume":"10","author":"Duong","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0125","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0952-7915(00)00112-6","article-title":"Immunity to listeria infection","volume":"12","author":"Edelson","year":"2000","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0130","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.4049\/jimmunol.162.4.2291","article-title":"Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria","volume":"162","author":"Elkins","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","article-title":"Immunology of tuberculosis","volume":"19","author":"Flynn","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0140","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijpharm.2005.03.035","article-title":"Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model","volume":"298","author":"Foged","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0145","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/infdis\/jit401","article-title":"CD8 T cell exhaustion in human visceral leishmaniasis","volume":"209","author":"Gautam","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0150","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/mi.2012.135","article-title":"Interleukin-17-dependent CXCL13 mediates mucosal vaccine-induced immunity against tuberculosis","volume":"6","author":"Gopal","year":"2013","journal-title":"Mucosal Immunol."},{"issue":"3 Pt A","key":"10.1016\/j.ijpharm.2015.09.059_bib0155","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejpb.2013.07.002","article-title":"Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review","volume":"85","author":"Hadinoto","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0160","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.addr.2011.05.021","article-title":"Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations","volume":"63","author":"Hamdy","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0165","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1086\/508217","article-title":"A live experimental vaccine against Burkholderia pseudomallei elicits CD4+ T cell-mediated immunity, priming T cells specific for 2 type III secretion system proteins","volume":"194","author":"Haque","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0170","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/498983","article-title":"Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection","volume":"193","author":"Haque","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0175","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1128\/IAI.73.9.5945-5951.2005","article-title":"Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection","volume":"73","author":"Healey","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0180","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/eji.200737169","article-title":"Antigen co-encapsulated with adjuvants efficiently drive protective T cell immunity","volume":"37","author":"Heit","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0185","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0190","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2567.2004.01878.x","article-title":"Of men, mice and pigs: looking at their plasmacytoid dendritic cells [corrected]","volume":"112","author":"Hochrein","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0195","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.vaccine.2014.02.027","article-title":"Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release","volume":"32","author":"Ilyinskii","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0200","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1021\/mp800027f","article-title":"Stabilization of tetanus toxoid encapsulated in PLGA microspheres","volume":"5","author":"Jiang","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0205","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1208\/s12248-012-9418-6","article-title":"Biodegradable particles as vaccine delivery systems: size matters","volume":"15","author":"Joshi","year":"2013","journal-title":"AAPS J."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0210","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijpharm.2012.04.043","article-title":"Enhanced stability of horseradish peroxidase encapsulated in acetalated dextran microparticles stored outside cold chain conditions","volume":"431","author":"Kanthamneni","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0215","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ijpharm.2011.10.034","article-title":"Optimization of rapamycin-loaded acetalated dextran microparticles for immunosuppression","volume":"422","author":"Kauffman","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0220","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1086\/341222","article-title":"Demonstration of a cell-mediated immune response in melioidosis","volume":"186","author":"Ketheesan","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0225","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2172-7-19","article-title":"The innate interferon gamma response of BALB\/c and C57BL\/6 mice to in vitro Burkholderia pseudomallei infection","volume":"7","author":"Koo","year":"2006","journal-title":"BMC Immunol."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0230","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/374546a0","article-title":"CpG motifs in bacterial DNA trigger direct B-cell activation","volume":"374","author":"Krieg","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0235","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.coi.2009.01.004","article-title":"Mechanism of action of clinically approved adjuvants","volume":"21","author":"Lambrecht","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0240","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1086\/315642","article-title":"Soluble granzymes are released during human endotoxemia and in patients with severe infection due to gram-negative bacteria","volume":"182","author":"Lauw","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0245","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jconrel.2004.07.029","article-title":"Mapping neutral microclimate pH in PLGA microspheres","volume":"101","author":"Li","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-1656(99)00107-8","article-title":"Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines","volume":"73","author":"Liljeqvist","year":"1999","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0255","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1477-3155-9-55","article-title":"Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines","volume":"9","author":"Mahapatro","year":"2011","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0260","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/eji.200737984","article-title":"Nanoparticles target distinct dendritic cell populations according to their size","volume":"38","author":"Manolova","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0265","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1021\/mp2003785","article-title":"Synthesis, optimization, and characterization of camptothecin-loaded acetalated dextran porous microparticles for pulmonary delivery","volume":"9","author":"Meenach","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0270","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cell clone: I. Definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"Mosmann","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0275","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1099\/jmm.0.45766-0","article-title":"Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis","volume":"53","author":"Nelson","year":"2004","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0280","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1016\/j.vaccine.2010.08.058","article-title":"Lipopolysaccharide from Burkholderia thailandensis E264 provides protection in a murine model of melioidosis","volume":"28","author":"Ngugi","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0285","doi-asserted-by":"crossref","first-page":"8381","DOI":"10.1016\/j.vaccine.2011.08.058","article-title":"A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection","volume":"29","author":"Nieves","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0290","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/CVI.00119-14","article-title":"A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis","volume":"21","author":"Nieves","year":"2014","journal-title":"Clin. Vaccine Immunol.: CVI"},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2005.10.011","article-title":"Natural killer cells in human health and disease","volume":"118","author":"Orange","year":"2006","journal-title":"Clin. Immunol."},{"issue":"198","key":"10.1016\/j.ijpharm.2015.09.059_bib0300","article-title":"Development of vaccines against Burkholderia pseudomallei","volume":"2","author":"Patel","year":"2011","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0305","series-title":"Fundamental Immunology","author":"Paul","year":"1994"},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0310","doi-asserted-by":"crossref","first-page":"e1488","DOI":"10.1371\/journal.pntd.0001488","article-title":"Melioidosis vaccines: a systematic review and appraisal of the potential to exploit biodefense vaccines for public health purposes","volume":"6","author":"Peacock","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0315","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/jac\/dkt320","article-title":"Liposomal resiquimod for the treatment of Leishmania donovani infection","volume":"69","author":"Peine","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.ijpharm.2015.09.059_bib0320","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1021\/mp4005172","article-title":"Treatment of experimental autoimmune encephalomyelitis by codelivery of disease associated peptide and dexamethasone in acetalated dextran microparticles","volume":"11","author":"Peine","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0325","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.provac.2014.07.007","article-title":"Evaluation of a outer membrane vesicle vaccine in nonhuman primates","volume":"8","author":"Petersen","year":"2014","journal-title":"Proc. Vaccinol."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0330","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1128\/IAI.01262-05","article-title":"Identification of Burkholderia pseudomallei genes required for the intracellular life cycle and in vivo virulence","volume":"74","author":"Pilatz","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.11.1.1","article-title":"Use of licensed vaccines for active immunization of the immunocompromised host","volume":"11","author":"Pirofski","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0340","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s10096-002-0768-3","article-title":"Peripheral blood lymphocyte subsets in acute human melioidosis","volume":"21","author":"Ramsay","year":"2002","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0345","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1476-8518-8-2","article-title":"CpG oligodeoxyribonucleotides protect mice from Burkholderia pseudomallei but not Francisella tularensis Schu S4 aerosols","volume":"8","author":"Rozak","year":"2010","journal-title":"J. Immune Based Ther. Vaccines"},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0350","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1007\/s11095-014-1419-y","article-title":"Biomaterials for nanoparticle vaccine delivery systems","volume":"31","author":"Sahdev","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0355","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1128\/IAI.67.7.3593-3600.1999","article-title":"Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei","volume":"67","author":"Santanirand","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0360","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.clinthera.2010.07.020","article-title":"Progress toward development of vaccines against melioidosis: a review","volume":"32","author":"Sarkar-Tyson","year":"2010","journal-title":"Clin. Ther."},{"issue":"5","key":"10.1016\/j.ijpharm.2015.09.059_bib0365","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s11095-013-0975-x","article-title":"Rapid vaccination using an acetalated dextran microparticulate subunit vaccine confers protection against triplicate challenge by Bacillus anthracis","volume":"30","author":"Schully","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0370","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1128\/IAI.01847-14","article-title":"Burkholderia pseudomallei capsular polysaccharide conjugates provide protection against acute melioidosis","volume":"82","author":"Scott","year":"2014","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0375","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.2147\/IJN.S64353","article-title":"Size-dependent accumulation of particles in lysosomes modulates dendritic cell function through impaired antigen degradation","volume":"9","author":"Seydoux","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0380","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2567.2005.02268.x","article-title":"Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles","volume":"117","author":"Shen","year":"2006","journal-title":"Immunology"},{"issue":"10","key":"10.1016\/j.ijpharm.2015.09.059_bib0385","article-title":"Development of Burkholderia mallei and pseudomallei vaccines","volume":"3","author":"Silva","year":"2013","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0390","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1128\/JVI.00239-09","article-title":"Acquisition of polyfunctionality by epstein-barr virus-specific CD8+ T cells correlates with increased resistance to galectin-1-mediated suppression","volume":"83","author":"Smith","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0395","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1126\/science.3107127","article-title":"Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production","volume":"236","author":"Snapper","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0400","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1099\/mic.0.27146-0","article-title":"Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis","volume":"150","author":"Stevens","year":"2004","journal-title":"Microbiology"},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0405","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1128\/IAI.00803-10","article-title":"Burkholderia pseudomallei proteins presented by monocyte-derived dendritic cells stimulate human memory T cells in vitro","volume":"79","author":"Tippayawat","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0410","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.drudis.2008.04.010","article-title":"Vaccines against intracellular bacterial pathogens","volume":"13","author":"Titball","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0415","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/cimm.2000.1673","article-title":"The immune response modifiers imiquimod and R-848 are potent activators of B lymphocytes","volume":"203","author":"Tomai","year":"2000","journal-title":"Cell Immunol."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0420","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.178.4063.871","article-title":"Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range","volume":"178","author":"Udenfriend","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0425","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1586\/14760584.2013.811208","article-title":"The use of toll-like receptor 7\/8 agonists as vaccine adjuvants","volume":"12","author":"Vasilakos","year":"2013","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0430","first-page":"147","article-title":"Melioidosis","author":"Vietri","year":"2007","journal-title":"Med. Aspects Biol. Warfare"},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0435","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1128\/IAI.74.3.1944-1948.2006","article-title":"A CpG oligonucleotide can protect mice from a low aerosol challenge dose of Burkholderia mallei","volume":"74","author":"Waag","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0440","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.vaccine.2005.10.032","article-title":"Encapsulation of proteins and peptides into biodegradable poly(d,L-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells","volume":"24","author":"Waeckerle-Men","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0445","doi-asserted-by":"crossref","first-page":"e0124667","DOI":"10.1371\/journal.pone.0124667","article-title":"Characterization of Burkholderia pseudomallei strains using a murine intraperitoneal infection model and in vitro macrophage assays","volume":"10","author":"Welkos","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.provac.2010.03.013","article-title":"Protective response to subunit vaccination against intranasal and challenge","volume":"2","author":"Whitlock","year":"2010","journal-title":"Proc. Vaccinol."},{"key":"10.1016\/j.ijpharm.2015.09.059_bib0455","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.antiviral.2004.07.002","article-title":"Resiquimod: a new immune response modifier with potential as a vaccine adjuvant for Th1 immune responses","volume":"64","author":"Wu","year":"2004","journal-title":"Antivir. Res."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851731530257X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851731530257X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:40:36Z","timestamp":1786131636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037851731530257X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":91,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S037851731530257X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2015.09.059","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of a biodegradable microparticulate polymer as a carrier for Burkholderia pseudomallei subunit vaccines in a mouse model of melioidosis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2015.09.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}